Catalyst Wire Dossier Catalyst Wire Dossier

ABILIFY ASIMTUFII

ARIPIPRAZOLE · Otsuka America Pharmaceutical, Inc
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABILIFY ASIMTUFII, covering 2023-04-27 to 2025-03-28. Get the full timeline:

Most recent: FDA Approved: ABILIFY ASIMTUFII — Supplemental Application (Otsuka America Pharmaceutical, Inc)

See pricing